159 related articles for article (PubMed ID: 21373194)
1. Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort.
Kigen G; Kimaiyo S; Nyandiko W; Faragher B; Sang E; Jakait B; Owen A; Back D; Gibbons S; Seden K; Khoo SH;
PLoS One; 2011 Feb; 6(2):e16800. PubMed ID: 21373194
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy.
Miller CD; El-Kholi R; Faragon JJ; Lodise TP
Pharmacotherapy; 2007 Oct; 27(10):1379-86. PubMed ID: 17896893
[TBL] [Abstract][Full Text] [Related]
3. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
4. Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy.
Yiu P; Nguyen NN; Holodniy M
Pharmacotherapy; 2011 May; 31(5):480-9. PubMed ID: 21923429
[TBL] [Abstract][Full Text] [Related]
5. Clinically Significant Drug-Drug Interaction in a Large Antiretroviral Treatment Centre in Lagos, Nigeria.
Oreagba IA; Usman SO; Oshikoya KA; Akinyede A; Agbaje E; Opanuga O; Akanmu S
J Popul Ther Clin Pharmacol; 2019 Jan; 26(1):e1-e19. PubMed ID: 31002484
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach.
Iniesta-Navalón C; Franco-Miguel JJ; Gascón-Cánovas JJ; Rentero-Redondo L
HIV Med; 2015 May; 16(5):273-9. PubMed ID: 25523089
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.
Oshikoya KA; Oreagba IA; Lawal S; Awodele O; Ogunleye OO; Senbanjo IO; Olayemi SO; Ezeaka VC; Temiye EO; Adeyemo TA; Opanuga O; Lesi OA; Akanmu SA
HIV AIDS (Auckl); 2014; 6():49-59. PubMed ID: 24741328
[TBL] [Abstract][Full Text] [Related]
8. [Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].
Cervero M; Torres R; Jusdado JJ; Pastor S; Agud JL
Med Clin (Barc); 2016 Apr; 146(8):339-45. PubMed ID: 26971988
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant drug interactions between antiretroviral and co-prescribed drugs in HIV infected patients: retrospective cohort study.
Al Sayed HAH; Sharif-Askari NS; Rahimi MR
Med Pharm Rep; 2022 Jul; 95(3):260-266. PubMed ID: 36060510
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients.
Jakeman B; Nasiri M; Ruth L; Morse C; Mahatme S; Patel N
Ann Pharmacother; 2017 May; 51(5):365-372. PubMed ID: 28367698
[TBL] [Abstract][Full Text] [Related]
11. Clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy.
So-Ngern A; Montakantikul P; Manosuthi W
Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1023-31. PubMed ID: 25417503
[TBL] [Abstract][Full Text] [Related]
12. Potential drug-drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia.
de Oliveira Costa J; Lau S; Medland N; Gibbons S; Schaffer AL; Pearson SA
Br J Clin Pharmacol; 2023 May; 89(5):1541-1553. PubMed ID: 36434744
[TBL] [Abstract][Full Text] [Related]
13. Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.
Regazzi M; Carvalho AC; Villani P; Matteelli A
Clin Pharmacokinet; 2014 Jun; 53(6):489-507. PubMed ID: 24777631
[TBL] [Abstract][Full Text] [Related]
14. Impact of polypharmacy on antiretroviral prescription in people living with HIV.
Guaraldi G; Menozzi M; Zona S; Calcagno A; Silva AR; Santoro A; Malagoli A; Dolci G; Mussi C; Mussini C; Cesari M; Khoo SH
J Antimicrob Chemother; 2017 Feb; 72(2):511-514. PubMed ID: 27834193
[TBL] [Abstract][Full Text] [Related]
15. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Hirasen K; van den Berg L; Miot J; Long LC; Fox MP
Drug Saf; 2018 Dec; 41(12):1343-1353. PubMed ID: 30043384
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
Manosuthi W; Sungkanuparph S; Tantanathip P; Lueangniyomkul A; Mankatitham W; Prasithsirskul W; Burapatarawong S; Thongyen S; Likanonsakul S; Thawornwa U; Prommool V; Ruxrungtham K;
Clin Infect Dis; 2009 Jun; 48(12):1752-9. PubMed ID: 19438397
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Marzolini C; Elzi L; Gibbons S; Weber R; Fux C; Furrer H; Chave JP; Cavassini M; Bernasconi E; Calmy A; Vernazza P; Khoo S; Ledergerber B; Back D; Battegay M;
Antivir Ther; 2010; 15(3):413-23. PubMed ID: 20516560
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India.
Pujari S; Dravid A; Gupte N; Joshi K; Bele V
Medscape J Med; 2008; 10(8):196. PubMed ID: 18924648
[TBL] [Abstract][Full Text] [Related]
19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries.
Maartens G; Decloedt E; Cohen K
Antivir Ther; 2009; 14(8):1039-43. PubMed ID: 20032533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
